NASDAQ:ADPT
Adaptive Biotechnologies
- Stock
Last Close
15.56
06/11 21:44
Market Cap
515.79M
Beta: 1.18
Volume Today
2.01M
Avg: 909.46K
PE Ratio
−2.72
PFCF: −2.92
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | ||
|---|---|---|---|---|---|---|---|---|---|
revenue | 38.45M - | 55.66M 44.77% | 85.07M 52.83% | 98.38M 15.65% | 154.34M 56.88% | 185.31M 20.06% | 170.28M 8.11% | 178.96M 5.10% | |
cost of revenue | 15.68M - | 19.67M 25.43% | 22.27M 13.25% | 22.53M 1.15% | 49.30M 118.82% | 57.91M 17.46% | 97.78M 68.86% | 72.08M 26.29% | |
gross profit | 22.77M - | 35.99M 58.09% | 62.80M 74.46% | 75.85M 20.79% | 105.04M 38.48% | 127.40M 21.28% | 72.49M 43.10% | 106.88M 47.43% | |
selling and marketing expenses | 16.77M - | 24.49M 46.05% | 38.45M 57.04% | 61.36M 59.57% | 95.47M 55.59% | 95.60M 0.14% | 88.58M 7.35% | 84.76M 4.31% | |
general and administrative expenses | 15.95M - | 20.41M 27.96% | 30.33M 48.62% | 49.54M 63.31% | 74.50M 50.40% | 88.53M 18.82% | 83.93M 5.19% | 72.81M 13.26% | |
selling general and administrative expenses | 32.71M - | 44.90M 37.23% | 68.78M 53.21% | 110.89M 61.22% | 169.97M 53.27% | 184.13M 8.33% | 172.51M 6.31% | 157.56M 8.66% | |
research and development expenses | 32.00M - | 39.16M 22.38% | 70.70M 80.57% | 116.07M 64.16% | 142.34M 22.63% | 141.76M 0.41% | 101.58M 28.34% | 102.95M 1.35% | |
other expenses | 1.69M - | 1.70M 0.30% | 1.70M 0.06% | 1.70M 0.29% | 1.70M 0.23% | 1.70M 0% | 27.13M 1,496.70% | 8.91M 67.16% | |
cost and expenses | 82.08M - | 105.42M 28.43% | 163.46M 55.06% | 251.20M 53.67% | 363.31M 44.63% | 385.49M 6.11% | 371.88M 3.53% | 341.51M 8.17% | |
operating expenses | 66.40M - | 85.75M 29.14% | 141.19M 64.65% | 228.67M 61.96% | 314.01M 37.32% | 327.58M 4.32% | 274.10M 16.33% | 269.43M 1.70% | |
interest expense | 4.24M - | 13.80M 225.63% | 11.58M 16.09% | ||||||
ebitda | -37.00M - | -43.76M 18.26% | -76.69M 75.27% | -151.11M 97.04% | -207.27M 37.16% | -194.43M 6.19% | -179.38M 7.74% | -128.76M 28.22% | |
operating income | -44.48M - | -49.76M 11.87% | -78.39M 57.55% | -152.82M 94.94% | -208.97M 36.74% | -200.19M 4.20% | -201.61M 0.71% | -162.55M 19.37% | |
depreciation and amortization | 5.80M - | 6M 3.52% | 1.70M 71.70% | 1.70M 0.29% | 1.70M 0.23% | 5.75M 238.73% | 22.23M 286.29% | 19.26M 13.38% | |
total other income expenses net | -840K - | 3.31M 493.93% | 9.79M 195.71% | 6.59M 32.65% | 1.67M 74.69% | -182K 110.91% | -23.70M 12,920.88% | 2.95M 112.47% | |
income before tax | -42.83M - | -46.45M 8.44% | -68.61M 47.71% | -146.23M 113.14% | -207.30M 41.76% | -200.37M 3.34% | -225.30M 12.45% | -159.59M 29.16% | |
income tax expense | -804K - | 3.31M 511.57% | -9.79M 395.71% | -6.59M 32.65% | -1.69M 74.40% | -57.90M 3,332.37% | -54K 99.91% | ||
net income | -42.83M - | -46.45M 8.44% | -58.82M 26.64% | -139.64M 137.39% | -205.61M 47.25% | -142.46M 30.71% | -225.25M 58.11% | -159.49M 29.19% | |
weighted average shs out | 105.43M - | 105.43M 0% | 69.17M 34.40% | 131.22M 89.71% | 140.35M 6.96% | 142.52M 1.54% | 144.38M 1.31% | 147.10M 1.88% | |
weighted average shs out dil | 105.43M - | 105.43M 0% | 69.17M 34.40% | 131.22M 89.71% | 140.35M 6.96% | 142.52M 1.54% | 144.38M 1.31% | 147.10M 1.88% | |
eps | -0.41 - | -0.44 7.32% | -0.85 93.18% | -1.06 24.71% | -1.46 37.74% | -1 31.51% | -1.56 56.00% | -1.08 30.77% | |
epsdiluted | -0.41 - | -0.44 7.32% | -0.85 93.18% | -1.06 24.71% | -1.46 37.74% | -1 31.51% | -1.56 56.00% | -1.08 30.77% |
All numbers in USD (except ratios and percentages)